Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
IRVING, Texas, May 15, 2013 /PRNewswire/ -- RBC Life Sciences, Inc. (OTCQB: RBCL), a provider of proprietary nutritional supplements, and wound care and pain management products, today reported consolidated net sales of $5.7 million for the first quarter ended March 31, 2013, a 6% decrease over the first quarter ended March 31, 2012. For the first quarter of 2013, the Company reported a net loss of $8,000, or $0.00 per diluted share, compared to a net loss of $73,000, or $0.00 per diluted share, during the first quarter of 2012.
Help employers find you! Check out all the jobs and post your resume.
